OC000459

· Oxagen Ltd

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for OC000459, covering 2009-02-24 to 2023-10-30. Get the full timeline:

Most recent: Clinical Trial Update: The Effects of OC000459 on Nasal Mediators [Phase 1, Phase 2]